In COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations, with fewer serious adverse events

Ann Intern Med. 2021 Jun;174(6):JC66. doi: 10.7326/ACPJ202106150-066. Epub 2021 Jun 1.

Abstract

Janjua S, Mathioudakis AG, Fortescue R, et al. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Cochrane Database Syst Rev. 2021;1:CD013198. 33448349.

Publication types

  • Comment

MeSH terms

  • Adult
  • Anti-Bacterial Agents / adverse effects
  • Antibiotic Prophylaxis
  • Disease Progression
  • Humans
  • Macrolides / adverse effects
  • Pulmonary Disease, Chronic Obstructive* / drug therapy
  • Quinolones* / therapeutic use
  • Tetracyclines / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • Quinolones
  • Tetracyclines